| Bioactivity | Lomedeucitinib (BMS-986322) is act by targeting receptor tyrosine protein kinase (TYK2). Lomedeucitinib can be used for the research of plaque psoriasis[1]. |
| Name | Lomedeucitinib |
| CAS | 2328068-29-5 |
| Formula | C18H17D3N6O4S |
| Molar Mass | 419.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lomedeucitinib by Bristol-Myers Squibb for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval. |
Lomedeucitinib
CAS: 2328068-29-5 F: C18H17D3N6O4S W: 419.47
Lomedeucitinib (BMS-986322) is act by targeting receptor tyrosine protein kinase (TYK2). Lomedeucitinib can be used for
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.